Dr. None Vimal Ravi, MD

Dr. Vimal Ravi practices at Cox Medical Center South in Springfield, Missouri, part of Lester E. Cox Medical Centers.

Dr. Vimal Ravi's NPI, 1578996419, was assigned on August 14, 2013. Dr. Vimal Ravi holds Missouri license 2019017130.

Dr. Vimal Ravi's primary practice is Cox Medical Center South, at 3801 South National Avenue, Springfield, MO 65807 in Greene County. The practice phone is (417) 269-6000.

Dr. Vimal Ravi's primary practice is Cox Medical Center South in Springfield, Missouri, part of Lester E. Cox Medical Centers. Dr. Vimal Ravi is also affiliated with Cox Monett Hospital. The medical group on file is CoxHealth Neurology. Dmand AI also links Dr. Vimal Ravi to 2 more group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Vimal Ravi practices, 4 sites in all. Vendor and product names are available with a free account.

Pulmonary disease is Dr. Vimal Ravi's primary specialty in the NPI Registry, under taxonomy code 207RP1001X. Dmand AI has Dr. Vimal Ravi's licenses on file in 2 states: Missouri and Pennsylvania.

CMS data shows 639 Medicare services from Dr. Vimal Ravi across 12 procedure codes in 2024, for 266 Medicare patients. Medicare paid $47,788 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 266 Medicare patients who saw Dr. Vimal Ravi in 2024. The largest group is 65 to 74, with 104 patients. 75% of them have high blood pressure, and 72% have high cholesterol. 19% are also on Medicaid. Their average risk score is 2.14, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Vimal Ravi's median patient age at 72, with 44% women.

In 2024, Dr. Vimal Ravi wrote 697 Medicare Part D claims for 100 patients. 32% of them were for generic drugs. CMS names the drug for 605 of them, across 14 drugs with 11 or more claims each, at $415,946 in total drug cost. In 2023, CMS named 416 claims across 9 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 82 out of 100 for Dr. Vimal Ravi for performance year 2024, reported as part of a group. Dr. Vimal Ravi accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 108 general payments to Dr. Vimal Ravi from 32 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 60% of the total. Intuitive Surgical, Inc. paid the most, $1,500.